Table 2.
Frequency and rate of answers to Q30 and Q31
| Question | Answers | Frequency | Rate |
|---|---|---|---|
| Q30. What is your preferred therapeutic option in a severe allergic asthma patient with an incomplete response to Anti-IgE and blood Eos≥150? | To add an Anti IL-5 drug | 80 | 28.1% |
| To switch to an anti IL5 | 111 | 38.9% | |
| Neither of the above | 28 | 9.8% | |
| I have not yet formed an opinion | 66 | 23.2% | |
| Q31. What is your preferred therapeutic option in a severe allergic asthma with an incomplete clinical response to anti-IL5 and Eos ≥150 | To add an Anti IgE drug | 113 | 39.6% |
| To switch to another Anti IL5 | 54 | 18.9% | |
| Neither of the above | 26 | 9.1% | |
| I have not yet formedan opinion | 92 | 32.3% |
Legend: Eos = Eosinophil; IL5 = interleukine 5, IgE = Immunoglobulin E.